| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/01616412.2016.1203096 |
| P698 | PubMed publication ID | 27367429 |
| P50 | author | Nuray Yazihan | Q87198845 |
| P2093 | author name string | Ayhan Bilir | |
| Mine Erguven | |||
| Yavuz Aras | |||
| Esin Aktas | |||
| P2860 | cites work | GSK3beta regulates differentiation and growth arrest in glioblastoma | Q28476300 |
| Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). | Q33350179 | ||
| GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity | Q33702416 | ||
| Water, water, everywhere: sodium and water balance and the injured brain | Q33840686 | ||
| Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia | Q34546517 | ||
| Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations. | Q34552031 | ||
| Midkine: a promising molecule for drug development to treat diseases of the central nervous system | Q35701268 | ||
| Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases | Q36160231 | ||
| Cell death mechanisms: cross-talk and role in disease | Q37704652 | ||
| The role of mitochondria in glioma pathophysiology | Q37736329 | ||
| Intracellular pathways underlying the effects of lithium. | Q37779225 | ||
| Targeting autophagy during cancer therapy to improve clinical outcomes | Q37858077 | ||
| Glioblastoma: pathology, molecular mechanisms and markers | Q38460865 | ||
| Sorafenib and lithium chloride combination treatment shows promising synergistic effects in human glioblastoma multiforme cells in vitro but midkine is not implicated | Q39025471 | ||
| Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β | Q39669643 | ||
| Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y. | Q39704067 | ||
| Carvedilol in glioma treatment alone and with imatinib in vitro | Q39732975 | ||
| In-vitro effects of the tyrosine kinase inhibitor imatinib on glioblastoma cell proliferation | Q39821325 | ||
| Glycogen synthase kinase-3beta regulates etoposide-induced apoptosis via Bcl-2 mediated caspase-3 activation in C3H10T1/2 cells | Q39858094 | ||
| Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase | Q40316727 | ||
| Apoptotic cell death induced by baccatin III, a precursor of paclitaxel, may occur without G(2)/M arrest | Q40919181 | ||
| Recurrent high-grade glioma | Q42906999 | ||
| Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment | Q43269529 | ||
| Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM. | Q46786527 | ||
| Erythropoietin changes contractility, cAMP, and nitrite levels of isolated rat hearts. | Q54559111 | ||
| P433 | issue | 9 | |
| P921 | main subject | imatinib | Q177094 |
| glioblastoma | Q282142 | ||
| P304 | page(s) | 766-774 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | Neurological Research | Q15765622 |
| P1476 | title | Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro | |
| P478 | volume | 38 |
| Q64963565 | Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review. |
| Q38709582 | Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling |
| Q42316508 | Patient-derived glioblastoma stem cells respond differentially to targeted therapies |
Search more.